Exagen Inc.
Exagen Inc. (XGN) Stock Overview
Explore Exagen Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
69.6M
P/E Ratio
-3.28
EPS (TTM)
$-0.93
ROE
-1.27%
XGN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Exagen Inc. (XGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 35.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.02.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.28 and a market capitalization of 69.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.